Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prevention of Salmonella, 32400-32403 [2013-12790]
Download as PDF
32400
Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices
Evaluations,’’ European Journal of Clinical
Nutrition, vol. 59, pp. 1191–1200, 2005.
19. Ford, G. T., M. Hastak, A. Mitra, and D.
J. Ringold, ‘‘Can Consumers Interpret
Nutrition Information in the Presence of a
Health Claim? A Laboratory Investigation,’’
Journal of Public Policy & Marketing, vol.
15, pp. 16–27, 1996.
20. Howlett, E., S. Burton, and J. Kozup,
‘‘How Modification of the Nutrition Facts
Panel Influences Consumers at Risk for
Heart Disease: The Case of Trans Fat,’’
Journal of Public Policy & Marketing, vol.
27, pp. 83–97, 2008.
21. Lando, A. M. and S. C. Lo, ‘‘SingleLarger-Portion-Size and Dual-Column
Nutrition Labeling may Help Consumers
Make More Healthful Food Choices,’’
Journal of the Academy of Nutrition and
Dietetics, vol. 113, pp. 241–250, 2013.
22. Roberto, C. A., M. A. Bragg, M. J.
Seamans, R. L. Mechulan, et al,
‘‘Evaluation of Consumer Understanding of
Different Front-of-Package Nutrition
Labels, 2010–2011,’’ Preventing Chronic
Disease, vol. 9, 120015. DOI: https://
dx.doi.org/10.5888/pcd9.120015.
23. Roberto, C. A., M. A. Bragg, M. B.
Schwartz, M. J. Seamans, et al, ‘‘Facts Up
Front Versus Traffic Light Food Labels. A
Randomized Controlled Trial,’’ American
Journal of Preventive Medicine, vol. 43, pp.
134–141, 2012b.
24. Roe, B., A. S. Levy, and B. M. Derby,
‘‘The Impact of Health Claims on
Consumer Search and Product Evaluation
Outcomes: Results from FDA Experimental
Data,’’ Journal of Public Policy &
Marketing, vol. 18, pp. 89–105, 1999.
25. Chandon, P. ‘‘How Package Design and
Package-Based Marketing Claims Lead to
Overeating.’’ Applied Economic
Perspectives and Policy, vol. 35, pp. 123–
147, 2013.
26. Chandon P. and B. Wansink, ‘‘Does Food
Marketing Need to Make Us Fat? A Review
and Solutions,’’ Nutrition Reviews, vol. 70,
pp. 571–593, 2012.
Dated: May 24, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–12824 Filed 5–29–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
TKELLEY on DSK3SPTVN1PROD with NOTICES
[Docket No. FDA–2013–N–0297]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Prevention of
Salmonella Enteritidis in Shell Eggs
During Production—Recordkeeping
and Registration
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
VerDate Mar<15>2010
16:25 May 29, 2013
Jkt 229001
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by July 1,
2013.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0660. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400T, Rockville, MD 20850, 301–796–
5733, domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUMMARY:
Prevention of Salmonella Enteritidis
in Shell Eggs During Production—
Recordkeeping and Registration
Provisions—21 CFR 118.10 and 118.11
(OMB Control Number 0910–0660)—
Extension
Shell eggs contaminated with
Salmonella Enteritidis (SE) are
responsible for more than 140,000
illnesses per year. The Public Health
Service Act (PHS Act) authorizes the
Secretary to make and enforce such
regulations as ‘‘are necessary to prevent
the introduction, transmission, or
spread of communicable diseases from
foreign countries into the States . . . or
from one State . . . into any other
State’’ (section 361(a) of the PHS Act).
This authority has been delegated to the
Commissioner of Food and Drugs.
Under section 402(a)(4) of the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) (21 U.S.C. 342(a)(4)), a food
is adulterated if it is prepared, packed,
or held under insanitary conditions
whereby it may have been contaminated
with filth or rendered injurious to
health. Under section 701(a) of the
FD&C Act (21 U.S.C. 371(a)), FDA is
authorized to issue regulations for the
efficient enforcement of the FD&C Act.
On July 9, 2009, FDA published in the
Federal Register a final rule that
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
established a regulation part 118 (21
CFR part 118) entitled ‘‘Prevention of
Salmonella Enteritidis in Shell Eggs
During Production, Storage, and
Transportation’’ (74 FR 33030) (the
Shell Eggs final rule’’). Part 118 requires
shell egg producers to implement
measures to prevent SE from
contaminating eggs on the farm and
from further growth during storage and
transportation, and requires these
producers to maintain records
concerning their compliance with the
rule and to register with FDA. As
described in more detail with regard to
each information collection provision of
part 118, each farm site with 3,000 or
more egg-laying hens that sells raw shell
eggs to the table egg market, other than
directly to the consumer, must
refrigerate, register, and keep certain
records. Farms that do not send all of
their eggs to treatment are also required
to have an SE prevention plan and to
test for SE.
Section 118.10 of FDA’s regulations
(21 CFR 118.10) requires recordkeeping
for all measures the farm takes to
prevent SE in its flocks. Since many
existing farms participate in voluntary
egg quality assurance programs, those
respondents may not have to collect any
additional information. Records are
maintained on file at each farm site and
examined there periodically by FDA
inspectors.
Section 118.10 also requires each farm
site with 3,000 or more egg-laying hens
that sells raw shell eggs to the table egg
market, other than directly to the
consumer, and does not have all of the
shell eggs treated, to design and
implement an SE prevention plan.
Section 118.10 requires recordkeeping
for each of the provisions included in
the plan and for plan review and
modifications if corrective actions are
taken.
Finally, § 118.11 of FDA’s regulations
(21 CFR 118.11) requires that each farm
covered by § 118.1(a) register with FDA
using Form FDA 3733. The term ‘‘Form
FDA 3733’’ refers to both the paper
version of the form and the electronic
system known as the Shell Egg Producer
Registration Module, which is available
at https://www.access.fda.gov. The
Agency strongly encourages electronic
registration because it is faster and more
convenient. The system the Agency has
developed can accept electronic
registrations 24 hours a day, 7 days a
week. A registering shell egg producer
will receive confirmation of electronic
registration instantaneously once all the
required fields on the registration screen
are completed. However, paper
registrations will also be accepted. Form
E:\FR\FM\30MYN1.SGM
30MYN1
32401
Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices
FDA 3733 is available for download for
registration by mail or CD–ROM.
Recordkeeping and registration are
necessary for the success of the SE
prevention measures. Written SE
prevention plans and records of actions
taken due to each provision are essential
for farms to implement SE prevention
plans effectively. Further, they are
essential for us to be able to determine
compliance. Information provided
under these regulations helps us to
In the Federal Register of March 27,
2013 (78 FR 18605), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. We received one letter in
response to the notice; however, the
letter did not contain comments
responsive to the four information
collection topics specified in the 60-day
notice.
FDA estimates the burden of this
collection of information as follows:
notify quickly the facilities that might
be affected by a deliberate or accidental
contamination of the food supply. In
addition, data collected through
registration is used to support our
enforcement activities.
Description of Respondents:
Respondents to this information
collection include farm sites with 3,000
or more egg-laying hens that sell raw
eggs to the table egg market, other than
directly to the consumer.
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
records per
recordkeeper
Number of
recordkeepers 2
Description and 21 CFR Section
Refrigeration Records, 118.10(a)(3)(iv) .............................
Testing,
Diversion,
and
Treatment
Records,
118.10(a)(3)(v–viii) (positive) 3 .......................................
Egg Testing, 118.10(a)(3)(vii) ............................................
Environmental Testing, 118.10(a)(3)(v) 3 ...........................
Testing,
Diversion,
and
Treatment
Records,
118.10(a)(3)(v–viii) (negative) 3 ......................................
Prevention Plan Review and Modifications, 118.10(a)(4)
Chick and Pullet Procurement Records, 118.10(a)(2) ......
Rodent and Other Pest Control, 118.10(a)(3)(ii) and Biosecurity Records,118.10(a)(3)(i) .....................................
Prevention Plan Design, 118.10(a)(1) ...............................
Cleaning and Disinfection Records, 118.10(a)(3)(iii) .........
Total Hours .................................................................
Total annual
records
Average burden
per recordkeeping
Total hours
2,600
52
135,200
0.5
67,600
343
331
6,308
52
7
23
17,836
2,317
145,084
0.5
8.3
0.25
8,918
19,231
36,271
5,965
331
4,731
1
1
1
5,965
331
4,731
0.5
10
0.5
2,983
3,310
2,366
9,462
150
331
52
1
1
492,024
150
331
0.5
20
0.5
246,012
3,000
166
........................
........................
........................
..........................
389,857
1 There
TKELLEY on DSK3SPTVN1PROD with NOTICES
are no capital costs or operating and maintenance costs associated with this collection of information.
2 Some records are kept on a by-farm basis and others are kept on a by-house basis.
3 Calculations include requirements for pullet and layer houses.
FDA is retaining most of the estimates
published in the Shell Eggs final rule
with regard to the estimated number of
respondents and the average burden per
recordkeeping (74 FR 33030 at 33089 to
33091). FDA bases the remaining
recordkeeping burden estimates and the
reporting burden estimates on its
experience implementing the final rule
and the number of registrations and
cancellations received in the past 3
years.
The number of recordkeepers
estimated in column 2 of Table 1 and all
other estimates discussed in this section
are drawn from estimates of the total
number of layer and pullet houses
affected by the Shell Eggs final rule (74
FR 33030 at 33078 to 33080). In the final
rule, we assumed that those farms that
were operating according to recognized
industry or State quality assurance
plans were already largely in
compliance with the plan design and
recordkeeping provisions discussed in
this section, and therefore would not
experience additional costs to comply
with recordkeeping provisions. We
found that 59 percent of farms with
more than 50,000 layers were members
of State or industry quality assurance
plans. Fewer than 8 percent of farms
VerDate Mar<15>2010
16:25 May 29, 2013
Jkt 229001
with fewer than 50,000 layers were
members of quality assurance plans.
Thus, we estimated the number of layer
farms incurring a new recordkeeping
burden because of the Shell Eggs final
rule to be 2,600, and the number of
houses affected to be 4,731. A detailed
breakdown of this estimation is shown
in Table 29 of the Shell Eggs final rule
(74 FR 33030 at 33078).
Prevention plan design
(§ 118.10(a)(1)) records will be kept on
a per farm basis but because the Shell
Eggs final rule has been fully
implemented, FDA assumes that new
prevention plan design will only be
undertaken by new entrants to the
industry. Refrigeration records
(§ 118.10(a)(3)(iv)) will also be kept on
a per farm basis so the estimated
number of recordkeepers for this
provision is 2,600.
Records of chick and pullet
procurement (§ 118.10(a)(2)), rodent and
other pest control (§ 118.10(a)(3)(ii)),
and biosecurity (§ 118.10(a)(3)(i)) will be
kept on a per house basis, so the
estimated number of recordkeepers for
these provisions is 4,731.
Records of cleaning and disinfection
(§ 118.10(a)(3)(iii)) will also be kept on
a per house basis, but will only need to
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
be kept in the event that a layer house
tests environmentally positive for SE.
Prevention plan review and
modifications (§ 118.10(a)(4)) will also
need to be performed every time a house
tests positive. As discussed in Section
V.F. of the Shell Eggs final rule (74 FR
33030 at 33078 to 33080), FDA
estimated that 7.0 percent will test
positive after the provisions of the rule
took effect. Therefore, the number of
recordkeepers for these provisions is
estimated to be 331 (4,731 houses ×
0.070) annually.
Records of testing, diversion, and
treatment (§ 118.10(a)(3)(v–viii)) will be
kept on a per house basis and will
include records on flocks from pullet
houses. In the Shell Eggs final rule, FDA
estimated that there are one third as
many pullet houses as there are layer
houses. Therefore the total number of
recordkeepers for these provisions is
6,308 (4,731 + (4,731/3)). The number of
annual records kept depends on
whether or not houses test positive for
SE. Annually, 343 layer and pullet
houses ((4,731 layer houses × 0.070) +
((4731/3 pullet houses) × 0.0075)) are
expected to test positive and 5,965 are
expected to test negative ((4,731 layer
E:\FR\FM\30MYN1.SGM
30MYN1
32402
Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices
houses × 0.930) + ((4731/3 pullet
houses) × 0.9925)).
We assume that refrigeration records
will be kept on a weekly basis on a per
farm basis under § 118.10(a)(3)(iv)). We
estimate that 2,600 recordkeepers will
maintain 52 records each for a total of
135,200 records and that it will take
approximately 0.5 hour per
recordkeeping. Thus, the total annual
burden for refrigeration records is
estimated to be 67,600 hours (135,200 ×
0.5 hour).
We assume that records of testing,
diversion, and treatment under
§ 118.10(a)(3)(v–viii)) will be kept
weekly in the event a layer house tests
environmentally positive for SE. We
estimate that 343 layer and pullet
houses will test positive and thus 343
recordkeepers will maintain 52 records
each for a total of 17,836 records and
that it will take approximately 0.5 hour
per recordkeeping. Thus, the total
annual burden for testing, diversion,
and treatment records in the event of a
positive test result is estimated to be
8,918 hours (17,836 × 0.5 hour).
Given a positive environmental test
for SE., we estimate the weighted
average number of egg tests per house
under § 118.10(a)(3)(vii)) to be 7. We
estimate that 331 recordkeepers will
maintain 7 records each for a total of
2,317 records and that it will take
approximately 8.3 hours per
recordkeeping. Thus, the total annual
burden for egg testing is estimated to be
19,231 hours (2,317 × 8.3 hours).
FDA estimates that all 1,577 pullet
and 4,731 layer houses not currently
testing (6,308 recordkeepers) will incur
the burden of a single environmental
test annually under § 118.10(a)(3)(v)).
The number of samples taken during the
test depends on whether a farm employs
the row based method (an average of 12
samples per house) or the random
sampling method (32 samples per
house). For the purposes of this analysis
we estimate that roughly 50 percent of
the houses affected will employ a row
based method and 50 percent will
employ a random sampling method,
implying an average of 23 samples per
house. Thus, we estimate that 6,308
recordkeepers will take 23 samples each
for a total of 145,084 samples. The time
burden of sampling is estimated on a
per swab sample basis. We estimate that
it will take approximately 15 minutes to
collect and pack each sample. Thus, the
total annual burden for environmental
testing is estimated to be 36,271 hours
(145,084 × 0.25 hour).
We estimate that records of testing,
diversion, and treatment under
§ 118.10(a)(3)(v–viii)) will be kept
annually in the event a layer house tests
environmentally negative for SE. We
estimate that 5,965 layer and pullet
houses will test negative and thus 5,965
recordkeepers will maintain one record
of that testing that will take
approximately 0.5 hour per record.
Thus, the total annual burden for
testing, diversion, and treatment records
in the event of a negative test result is
estimated to be 2,983 hours (5,965 × 0.5
hour).
Prevention plan review and
modifications under § 118.10(a)(4)) will
need to be performed every time a house
tests positive. As discussed, we estimate
that 331 layer houses will test positive
requiring plan review and modifications
and that it will take 10 hours to
complete this work. Thus, the total
annual burden for prevention plan
review and modifications in the event of
a positive test result is estimated to be
3,310 hours (331 × 10 hours).
We estimate that chick and pullet
procurement records under
§ 118.10(a)(2) will be kept roughly once
annually per layer house basis. We
estimate that 4,731 layer houses will
maintain 1 record each and that it will
take approximately 0.5 hour per
recordkeeping. Thus, the total annual
burden for chick and pullet
procurement recordkeeping is estimated
to be 2,366 hours (4,731 × 0.5 hour).
We estimate that rodent and other
pest control records under
§ 118.10(a)(3)(ii)) and biosecurity
records under § 118.10(a)(3)(i) will be
kept weekly on a per layer house basis.
We assume that 4,731 layer houses will
maintain a weekly record under each
provision. Thus, we estimate 9,462
recordkeepers will maintain 52 records
each for a total of 492,024 records. We
estimate a recordkeeping burden of 0.5
hours per record for a total of 246,012
burden hours (492,024 × 0.5 hour).
New prevention plan design required
by § 118.10(a)(1) will only be
undertaken by new farms and records
will be kept on a per farm basis. We
estimate that there are 150 new farm
registrations annually and we assume
that this reflects 150 new farms
requiring prevention plan design. We
estimate that it will take 20 hours to
complete this work. Thus, the total
annual burden for prevention plan
design is estimated to be 3,000 hours
(150 × 20 hours).
Cleaning and disinfection
recordkeeping under § 118.10(a)(3)(iii)
will need to be performed every time a
house tests positive. As discussed, we
estimate that 331 layer houses will test
positive requiring 1 record each and that
it will take approximately 0.5 hour per
recordkeeping. Thus, the total annual
burden for cleaning and disinfection
recordkeeping in the event of a positive
test result is estimated to be 166 hours
(331 × 0.5 hour).
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
responses per
respondent
Description and 21 CFR
Section
FDA Form No.
Number of
respondents
Total annual
responses
Registrations or Updates,
118.11.
Cancellations, 118.11 ........
Form FDA 3733 2 ..............
150
1
150
Form FDA 3733 .................
15
1
15
Total ............................
............................................
........................
........................
........................
Average burden
per response
2.3
1
..........................
Total hours
345
15
360
TKELLEY on DSK3SPTVN1PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
2 The term ‘‘Form FDA 3733’’ refers to both the paper version of the form and the electronic system known as the Shell Egg Producer Registration Module, which is available at https://www.access.fda.gov per § 118.11(b)(1).
This estimate is based on FDA’s
experience implementing the Shell Eggs
final rule and the average number of
new Shell Egg Producer registrations
and cancellations received in the past 3
VerDate Mar<15>2010
16:25 May 29, 2013
Jkt 229001
years under § 118.11. Based on FDA
experience with implementing the
registration provisions of the Shell Eggs
final rule, which had staggered
compliance dates and gave producers
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
with fewer than 50,000 but at least 3,000
laying hens until July 9, 2012, to register
(74 FR 33030 at 33034), FDA expects
that it will receive fewer registrations or
updates each year over the next 3 years,
E:\FR\FM\30MYN1.SGM
30MYN1
Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices
reflecting compliance with the final
rule’s registration deadlines. FDA
estimates that it will receive 200
registrations or updates in 2013, 150
registrations or updates in 2014 and 100
registrations or updates in 2015, for an
average of 150 registrations or updates
per year over the next 3 years. FDA
received 12 cancellations in 2011 and
19 cancellations in 2012. Based on this
experience, FDA estimates that it will
receive approximately 15 cancellations
per year over the next 3 years.
FDA estimated in the Shell Eggs final
rule that listing the information required
by the final rule and presenting it in a
format that will meet the Agency’s
registration regulations will require a
burden of approximately 2.3 hours per
average registration. As detailed in
section V.F. of the final rule (see 74 FR
33030 at 33080), FDA estimates that it
will take the average farm 2.3 hours to
register taking into account that some
respondents completing the registration
may not have readily available Internet
access. Thus, the total annual burden for
new Shell Egg Producer registrations or
updates is estimated to be 345 hours
(150 × 2.3 hours).
FDA estimates cancelling a
registration will, on average, require a
burden of approximately 1 hour, taking
into account that some respondents may
not have readily available Internet
access. Thus, the total annual burden for
cancelling Shell Egg Producer
registrations is estimated to be 15 hours
(15 cancellations × 1 hour).
Dated: May 23, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–12790 Filed 5–29–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0001]
Arthritis Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
TKELLEY on DSK3SPTVN1PROD with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Arthritis
Advisory Committee.
General Function of the Committee:
To provide advice and
VerDate Mar<15>2010
16:25 May 29, 2013
Jkt 229001
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on July 22, 2013, from 8 a.m. to 4
p.m.
Location: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (rm.
1503), Silver Spring, MD 20993–0002.
Information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/default.htm; under
the heading ‘‘Resources for You,’’ click
on ‘‘Public Meetings at the FDA White
Oak Campus.’’ Please note that visitors
to the White Oak Campus must enter
through Building 1.
Contact Person: Cindy Hong, Center
for Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, rm. 2417,
Silver Spring, MD 20993–0002, 301–
796–9001, Fax: 301–847–8533, email:
AAC@fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
Agenda: On July 22, 2013, the
committee will discuss the Assessment
of SpondyloArthritis international
Society classification criteria for axial
spondyloarthritis and the implications
of using these criteria for drug approval.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
PO 00000
Frm 00039
Fmt 4703
Sfmt 9990
32403
submissions may be made to the contact
person on or before July 8, 2013. Oral
presentations from the public will be
scheduled between approximately 1
p.m. and 2 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before June 27,
2013. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by June 28, 2013.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Cindy Hong
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: May 24, 2013.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2013–12839 Filed 5–29–13; 8:45 am]
BILLING CODE 4160–01–P
E:\FR\FM\30MYN1.SGM
30MYN1
Agencies
[Federal Register Volume 78, Number 104 (Thursday, May 30, 2013)]
[Notices]
[Pages 32400-32403]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12790]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-0297]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Prevention of
Salmonella Enteritidis in Shell Eggs During Production--Recordkeeping
and Registration
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by July 1,
2013.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0660.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400T,
Rockville, MD 20850, 301-796-5733, domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Prevention of Salmonella Enteritidis in Shell Eggs During Production--
Recordkeeping and Registration Provisions--21 CFR 118.10 and 118.11
(OMB Control Number 0910-0660)--Extension
Shell eggs contaminated with Salmonella Enteritidis (SE) are
responsible for more than 140,000 illnesses per year. The Public Health
Service Act (PHS Act) authorizes the Secretary to make and enforce such
regulations as ``are necessary to prevent the introduction,
transmission, or spread of communicable diseases from foreign countries
into the States . . . or from one State . . . into any other State''
(section 361(a) of the PHS Act). This authority has been delegated to
the Commissioner of Food and Drugs. Under section 402(a)(4) of the
Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C.
342(a)(4)), a food is adulterated if it is prepared, packed, or held
under insanitary conditions whereby it may have been contaminated with
filth or rendered injurious to health. Under section 701(a) of the FD&C
Act (21 U.S.C. 371(a)), FDA is authorized to issue regulations for the
efficient enforcement of the FD&C Act.
On July 9, 2009, FDA published in the Federal Register a final rule
that established a regulation part 118 (21 CFR part 118) entitled
``Prevention of Salmonella Enteritidis in Shell Eggs During Production,
Storage, and Transportation'' (74 FR 33030) (the Shell Eggs final
rule''). Part 118 requires shell egg producers to implement measures to
prevent SE from contaminating eggs on the farm and from further growth
during storage and transportation, and requires these producers to
maintain records concerning their compliance with the rule and to
register with FDA. As described in more detail with regard to each
information collection provision of part 118, each farm site with 3,000
or more egg-laying hens that sells raw shell eggs to the table egg
market, other than directly to the consumer, must refrigerate,
register, and keep certain records. Farms that do not send all of their
eggs to treatment are also required to have an SE prevention plan and
to test for SE.
Section 118.10 of FDA's regulations (21 CFR 118.10) requires
recordkeeping for all measures the farm takes to prevent SE in its
flocks. Since many existing farms participate in voluntary egg quality
assurance programs, those respondents may not have to collect any
additional information. Records are maintained on file at each farm
site and examined there periodically by FDA inspectors.
Section 118.10 also requires each farm site with 3,000 or more egg-
laying hens that sells raw shell eggs to the table egg market, other
than directly to the consumer, and does not have all of the shell eggs
treated, to design and implement an SE prevention plan. Section 118.10
requires recordkeeping for each of the provisions included in the plan
and for plan review and modifications if corrective actions are taken.
Finally, Sec. 118.11 of FDA's regulations (21 CFR 118.11) requires
that each farm covered by Sec. 118.1(a) register with FDA using Form
FDA 3733. The term ``Form FDA 3733'' refers to both the paper version
of the form and the electronic system known as the Shell Egg Producer
Registration Module, which is available at https://www.access.fda.gov.
The Agency strongly encourages electronic registration because it is
faster and more convenient. The system the Agency has developed can
accept electronic registrations 24 hours a day, 7 days a week. A
registering shell egg producer will receive confirmation of electronic
registration instantaneously once all the required fields on the
registration screen are completed. However, paper registrations will
also be accepted. Form
[[Page 32401]]
FDA 3733 is available for download for registration by mail or CD-ROM.
Recordkeeping and registration are necessary for the success of the
SE prevention measures. Written SE prevention plans and records of
actions taken due to each provision are essential for farms to
implement SE prevention plans effectively. Further, they are essential
for us to be able to determine compliance. Information provided under
these regulations helps us to notify quickly the facilities that might
be affected by a deliberate or accidental contamination of the food
supply. In addition, data collected through registration is used to
support our enforcement activities.
Description of Respondents: Respondents to this information
collection include farm sites with 3,000 or more egg-laying hens that
sell raw eggs to the table egg market, other than directly to the
consumer.
In the Federal Register of March 27, 2013 (78 FR 18605), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. We received one letter in response to the
notice; however, the letter did not contain comments responsive to the
four information collection topics specified in the 60-day notice.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Number of Average burden
Description and 21 CFR Section recordkeepers records per Total annual per Total hours
\2\ recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
Refrigeration Records, 2,600 52 135,200 0.5 67,600
118.10(a)(3)(iv)...............
Testing, Diversion, and 343 52 17,836 0.5 8,918
Treatment Records,
118.10(a)(3)(v-viii) (positive)
\3\............................
Egg Testing, 118.10(a)(3)(vii).. 331 7 2,317 8.3 19,231
Environmental Testing, 6,308 23 145,084 0.25 36,271
118.10(a)(3)(v) \3\............
Testing, Diversion, and 5,965 1 5,965 0.5 2,983
Treatment Records,
118.10(a)(3)(v-viii) (negative)
\3\............................
Prevention Plan Review and 331 1 331 10 3,310
Modifications, 118.10(a)(4)....
Chick and Pullet Procurement 4,731 1 4,731 0.5 2,366
Records, 118.10(a)(2)..........
Rodent and Other Pest Control, 9,462 52 492,024 0.5 246,012
118.10(a)(3)(ii) and
Biosecurity
Records,118.10(a)(3)(i)........
Prevention Plan Design, 150 1 150 20 3,000
118.10(a)(1)...................
Cleaning and Disinfection 331 1 331 0.5 166
Records, 118.10(a)(3)(iii).....
-------------------------------------------------------------------------------
Total Hours................. .............. .............. .............. .............. 389,857
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
\2\ Some records are kept on a by-farm basis and others are kept on a by-house basis.
\3\ Calculations include requirements for pullet and layer houses.
FDA is retaining most of the estimates published in the Shell Eggs
final rule with regard to the estimated number of respondents and the
average burden per recordkeeping (74 FR 33030 at 33089 to 33091). FDA
bases the remaining recordkeeping burden estimates and the reporting
burden estimates on its experience implementing the final rule and the
number of registrations and cancellations received in the past 3 years.
The number of recordkeepers estimated in column 2 of Table 1 and
all other estimates discussed in this section are drawn from estimates
of the total number of layer and pullet houses affected by the Shell
Eggs final rule (74 FR 33030 at 33078 to 33080). In the final rule, we
assumed that those farms that were operating according to recognized
industry or State quality assurance plans were already largely in
compliance with the plan design and recordkeeping provisions discussed
in this section, and therefore would not experience additional costs to
comply with recordkeeping provisions. We found that 59 percent of farms
with more than 50,000 layers were members of State or industry quality
assurance plans. Fewer than 8 percent of farms with fewer than 50,000
layers were members of quality assurance plans. Thus, we estimated the
number of layer farms incurring a new recordkeeping burden because of
the Shell Eggs final rule to be 2,600, and the number of houses
affected to be 4,731. A detailed breakdown of this estimation is shown
in Table 29 of the Shell Eggs final rule (74 FR 33030 at 33078).
Prevention plan design (Sec. 118.10(a)(1)) records will be kept on
a per farm basis but because the Shell Eggs final rule has been fully
implemented, FDA assumes that new prevention plan design will only be
undertaken by new entrants to the industry. Refrigeration records
(Sec. 118.10(a)(3)(iv)) will also be kept on a per farm basis so the
estimated number of recordkeepers for this provision is 2,600.
Records of chick and pullet procurement (Sec. 118.10(a)(2)),
rodent and other pest control (Sec. 118.10(a)(3)(ii)), and biosecurity
(Sec. 118.10(a)(3)(i)) will be kept on a per house basis, so the
estimated number of recordkeepers for these provisions is 4,731.
Records of cleaning and disinfection (Sec. 118.10(a)(3)(iii)) will
also be kept on a per house basis, but will only need to be kept in the
event that a layer house tests environmentally positive for SE.
Prevention plan review and modifications (Sec. 118.10(a)(4)) will also
need to be performed every time a house tests positive. As discussed in
Section V.F. of the Shell Eggs final rule (74 FR 33030 at 33078 to
33080), FDA estimated that 7.0 percent will test positive after the
provisions of the rule took effect. Therefore, the number of
recordkeepers for these provisions is estimated to be 331 (4,731 houses
x 0.070) annually.
Records of testing, diversion, and treatment (Sec. 118.10(a)(3)(v-
viii)) will be kept on a per house basis and will include records on
flocks from pullet houses. In the Shell Eggs final rule, FDA estimated
that there are one third as many pullet houses as there are layer
houses. Therefore the total number of recordkeepers for these
provisions is 6,308 (4,731 + (4,731/3)). The number of annual records
kept depends on whether or not houses test positive for SE. Annually,
343 layer and pullet houses ((4,731 layer houses x 0.070) + ((4731/3
pullet houses) x 0.0075)) are expected to test positive and 5,965 are
expected to test negative ((4,731 layer
[[Page 32402]]
houses x 0.930) + ((4731/3 pullet houses) x 0.9925)).
We assume that refrigeration records will be kept on a weekly basis
on a per farm basis under Sec. 118.10(a)(3)(iv)). We estimate that
2,600 recordkeepers will maintain 52 records each for a total of
135,200 records and that it will take approximately 0.5 hour per
recordkeeping. Thus, the total annual burden for refrigeration records
is estimated to be 67,600 hours (135,200 x 0.5 hour).
We assume that records of testing, diversion, and treatment under
Sec. 118.10(a)(3)(v-viii)) will be kept weekly in the event a layer
house tests environmentally positive for SE. We estimate that 343 layer
and pullet houses will test positive and thus 343 recordkeepers will
maintain 52 records each for a total of 17,836 records and that it will
take approximately 0.5 hour per recordkeeping. Thus, the total annual
burden for testing, diversion, and treatment records in the event of a
positive test result is estimated to be 8,918 hours (17,836 x 0.5
hour).
Given a positive environmental test for SE., we estimate the
weighted average number of egg tests per house under Sec.
118.10(a)(3)(vii)) to be 7. We estimate that 331 recordkeepers will
maintain 7 records each for a total of 2,317 records and that it will
take approximately 8.3 hours per recordkeeping. Thus, the total annual
burden for egg testing is estimated to be 19,231 hours (2,317 x 8.3
hours).
FDA estimates that all 1,577 pullet and 4,731 layer houses not
currently testing (6,308 recordkeepers) will incur the burden of a
single environmental test annually under Sec. 118.10(a)(3)(v)). The
number of samples taken during the test depends on whether a farm
employs the row based method (an average of 12 samples per house) or
the random sampling method (32 samples per house). For the purposes of
this analysis we estimate that roughly 50 percent of the houses
affected will employ a row based method and 50 percent will employ a
random sampling method, implying an average of 23 samples per house.
Thus, we estimate that 6,308 recordkeepers will take 23 samples each
for a total of 145,084 samples. The time burden of sampling is
estimated on a per swab sample basis. We estimate that it will take
approximately 15 minutes to collect and pack each sample. Thus, the
total annual burden for environmental testing is estimated to be 36,271
hours (145,084 x 0.25 hour).
We estimate that records of testing, diversion, and treatment under
Sec. 118.10(a)(3)(v-viii)) will be kept annually in the event a layer
house tests environmentally negative for SE. We estimate that 5,965
layer and pullet houses will test negative and thus 5,965 recordkeepers
will maintain one record of that testing that will take approximately
0.5 hour per record. Thus, the total annual burden for testing,
diversion, and treatment records in the event of a negative test result
is estimated to be 2,983 hours (5,965 x 0.5 hour).
Prevention plan review and modifications under Sec. 118.10(a)(4))
will need to be performed every time a house tests positive. As
discussed, we estimate that 331 layer houses will test positive
requiring plan review and modifications and that it will take 10 hours
to complete this work. Thus, the total annual burden for prevention
plan review and modifications in the event of a positive test result is
estimated to be 3,310 hours (331 x 10 hours).
We estimate that chick and pullet procurement records under Sec.
118.10(a)(2) will be kept roughly once annually per layer house basis.
We estimate that 4,731 layer houses will maintain 1 record each and
that it will take approximately 0.5 hour per recordkeeping. Thus, the
total annual burden for chick and pullet procurement recordkeeping is
estimated to be 2,366 hours (4,731 x 0.5 hour).
We estimate that rodent and other pest control records under Sec.
118.10(a)(3)(ii)) and biosecurity records under Sec. 118.10(a)(3)(i)
will be kept weekly on a per layer house basis. We assume that 4,731
layer houses will maintain a weekly record under each provision. Thus,
we estimate 9,462 recordkeepers will maintain 52 records each for a
total of 492,024 records. We estimate a recordkeeping burden of 0.5
hours per record for a total of 246,012 burden hours (492,024 x 0.5
hour).
New prevention plan design required by Sec. 118.10(a)(1) will only
be undertaken by new farms and records will be kept on a per farm
basis. We estimate that there are 150 new farm registrations annually
and we assume that this reflects 150 new farms requiring prevention
plan design. We estimate that it will take 20 hours to complete this
work. Thus, the total annual burden for prevention plan design is
estimated to be 3,000 hours (150 x 20 hours).
Cleaning and disinfection recordkeeping under Sec.
118.10(a)(3)(iii) will need to be performed every time a house tests
positive. As discussed, we estimate that 331 layer houses will test
positive requiring 1 record each and that it will take approximately
0.5 hour per recordkeeping. Thus, the total annual burden for cleaning
and disinfection recordkeeping in the event of a positive test result
is estimated to be 166 hours (331 x 0.5 hour).
Table 2--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Description and 21 CFR Section FDA Form No. Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Registrations or Updates, 118.11......... Form FDA 3733 \2\........... 150 1 150 2.3 345
Cancellations, 118.11.................... Form FDA 3733............... 15 1 15 1 15
--------------------------------------------------------------------------------------------------------------
Total................................ ............................ .............. .............. .............. ............... 360
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ The term ``Form FDA 3733'' refers to both the paper version of the form and the electronic system known as the Shell Egg Producer Registration
Module, which is available at https://www.access.fda.gov per Sec. 118.11(b)(1).
This estimate is based on FDA's experience implementing the Shell
Eggs final rule and the average number of new Shell Egg Producer
registrations and cancellations received in the past 3 years under
Sec. 118.11. Based on FDA experience with implementing the
registration provisions of the Shell Eggs final rule, which had
staggered compliance dates and gave producers with fewer than 50,000
but at least 3,000 laying hens until July 9, 2012, to register (74 FR
33030 at 33034), FDA expects that it will receive fewer registrations
or updates each year over the next 3 years,
[[Page 32403]]
reflecting compliance with the final rule's registration deadlines. FDA
estimates that it will receive 200 registrations or updates in 2013,
150 registrations or updates in 2014 and 100 registrations or updates
in 2015, for an average of 150 registrations or updates per year over
the next 3 years. FDA received 12 cancellations in 2011 and 19
cancellations in 2012. Based on this experience, FDA estimates that it
will receive approximately 15 cancellations per year over the next 3
years.
FDA estimated in the Shell Eggs final rule that listing the
information required by the final rule and presenting it in a format
that will meet the Agency's registration regulations will require a
burden of approximately 2.3 hours per average registration. As detailed
in section V.F. of the final rule (see 74 FR 33030 at 33080), FDA
estimates that it will take the average farm 2.3 hours to register
taking into account that some respondents completing the registration
may not have readily available Internet access. Thus, the total annual
burden for new Shell Egg Producer registrations or updates is estimated
to be 345 hours (150 x 2.3 hours).
FDA estimates cancelling a registration will, on average, require a
burden of approximately 1 hour, taking into account that some
respondents may not have readily available Internet access. Thus, the
total annual burden for cancelling Shell Egg Producer registrations is
estimated to be 15 hours (15 cancellations x 1 hour).
Dated: May 23, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-12790 Filed 5-29-13; 8:45 am]
BILLING CODE 4160-01-P